| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4215921 | Revue des Maladies Respiratoires Actualités | 2012 | 5 Pages |
Abstract
French Intergroup (IFCT) with French NCI support, initiated a large prospective study, Biomarqueurs-France, to analyse the impact of the 17 000 routine yearly biomarkers analyses performed, by regional molecular biology platforms, on the routine care of French patients. This study will contribute to validate the biomarkers use, as early as at time of cancer diagnosis. Those biomarkers currently help us, or will help us in near future, for the routine care of lung cancer patients.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
E. Bergot, G. Levallet, L. Reviron-Rabec, C. Creveuil, E. Lechapt, G. Zalcman,